Goldman Sachs’s Adamas Pharmaceuticals ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $190K | Sell |
|
|||||
|
2021
Q2 | $338K | Buy |
|
|||||
|
2021
Q1 | $120K | Sell |
|
|||||
|
2020
Q4 | $168K | Sell |
|
|||||
|
2020
Q3 | $223K | Sell |
|
|||||
|
2020
Q2 | $265K | Buy |
|
|||||
|
2020
Q1 | $252K | Sell |
|
|||||
|
2019
Q4 | $361K | Sell |
|
|||||
|
2019
Q3 | $949K | Sell |
|
|||||
|
2019
Q2 | $1.16M | Buy |
|
|||||
|
2019
Q1 | $812K | Buy |
|
|||||
|
2018
Q4 | $814K | Buy |
|
|||||
|
2018
Q3 | $1.86M | Buy |
|
|||||
|
2018
Q2 | $716K | Sell |
|
|||||
|
2018
Q1 | $2.51M | Sell |
|
|||||
|
2017
Q4 | $5.83M | Buy |
|
|||||
|
2017
Q3 | $2.15M | Buy |
|
|||||
|
2017
Q2 | $996K | Sell |
|
|||||
|
2017
Q1 | $1.07M | Buy |
|
|||||
|
2016
Q4 | $329K | Buy |
|
|||||
|
2016
Q3 | $247K | Buy |
|
|||||
|
2016
Q2 | $189K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $304K | Sell |
|
|||||
|
2015
Q3 | $270K | Buy |
|
|||||
|
2015
Q2 | $261K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $201K | Sell |
|
|||||
|
2014
Q3 | $260K | Sell |
|
|||||
|
2014
Q2 | $324K | Buy |
|